for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Novartis: Cosentyx Gets Positive CHMP Opinion For Pediatric Psoriasis

June 26 (Reuters) - Novartis AG:

* NOVARTIS COSENTYX® GAINS POSITIVE CHMP OPINION FOR PEDIATRIC PSORIASIS, REINFORCING ESTABLISHED EFFICACY AND SAFETY PROFILE

* CHMP OPINION BASED ON TWO PHASE III STUDIES SHOWING COSENTYX PROVIDES FAST AND STRONG SKIN CLEARANCE AND SIGNIFICANT IMPROVEMENT IN QUALITY OF LIFE(1)

* EMA CHMP POSITIVE OPINION PAVES WAY FOR COSENTYX(®) TO BECOME A FIRST-LINE SYSTEMIC TREATMENT IN PEDIATRIC PSORIASIS Source text for Eikon: Further company coverage: (Reporting by Berlin Speed Desk)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up